Wells Fargo’s Avidity Biosciences RNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.26M | Buy |
255,598
+34,812
| +16% | +$989K | ﹤0.01% | 1968 |
|
|
2025
Q1 | $6.52M | Buy |
220,786
+48,216
| +28% | +$1.42M | ﹤0.01% | 1966 |
|
|
2024
Q4 | $5.02M | Sell |
172,570
-2,771
| -2% | -$80.6K | ﹤0.01% | 2138 |
|
|
2024
Q3 | $8.05M | Buy |
175,341
+41,468
| +31% | +$1.9M | ﹤0.01% | 1828 |
|
|
2024
Q2 | $5.47M | Sell |
133,873
-24,102
| -15% | -$985K | ﹤0.01% | 1994 |
|
|
2024
Q1 | $4.03M | Sell |
157,975
-32,753
| -17% | -$836K | ﹤0.01% | 2186 |
|
|
2023
Q4 | $1.73M | Sell |
190,728
-10,399
| -5% | -$94.1K | ﹤0.01% | 2736 |
|
|
2023
Q3 | $1.28M | Sell |
201,127
-22,771
| -10% | -$145K | ﹤0.01% | 2912 |
|
|
2023
Q2 | $2.48M | Buy |
223,898
+91,675
| +69% | +$1.02M | ﹤0.01% | 2584 |
|
|
2023
Q1 | $2.03M | Buy |
132,223
+78,896
| +148% | +$1.21M | ﹤0.01% | 2674 |
|
|
2022
Q4 | $1.18M | Sell |
53,327
-712
| -1% | -$15.8K | ﹤0.01% | 2956 |
|
|
2022
Q3 | $882K | Sell |
54,039
-28,505
| -35% | -$465K | ﹤0.01% | 3108 |
|
|
2022
Q2 | $1.2M | Buy |
82,544
+1,535
| +2% | +$22.3K | ﹤0.01% | 2989 |
|
|
2022
Q1 | $1.5M | Sell |
81,009
-44,761
| -36% | -$827K | ﹤0.01% | 3345 |
|
|
2021
Q4 | $2.99M | Buy |
125,770
+5,658
| +5% | +$134K | ﹤0.01% | 2915 |
|
|
2021
Q3 | $2.96M | Buy |
120,112
+53,403
| +80% | +$1.32M | ﹤0.01% | 3177 |
|
|
2021
Q2 | $1.65M | Sell |
66,709
-20,532
| -24% | -$508K | ﹤0.01% | 3659 |
|
|
2021
Q1 | $1.9M | Buy |
87,241
+6,317
| +8% | +$138K | ﹤0.01% | 3527 |
|
|
2020
Q4 | $2.07M | Buy |
80,924
+27,557
| +52% | +$703K | ﹤0.01% | 3433 |
|
|
2020
Q3 | $1.5M | Buy |
+53,367
| New | +$1.5M | ﹤0.01% | 3479 |
|